Aprepitant Teva 125 mg + 80 mg tvrde kapsule
| Name | Aprepitant Teva 125 mg + 80 mg tvrde kapsule |
|---|---|
| Marketing Authorisation Number | HR-H-083770930 |
| Active Substance | aprepitant |
| Composition | jedna kapsula od 125 mg sadrži 125 mg aprepitanta jedna kapsula od 80 mg sadrži 80 mg aprepitanta |
| Pharmaceutical Form | kapsula, tvrda |
| Manufacturer | Teva Operations Poland Sp. z o.o., Krakow, Poljska Merckle GmbH, Blaubeuren, Baden-Wuerttemberg, Njemačka Rontis Hellas Medical and Pharmaceutical Products S.A., Atena, Maroussi, Grčka |
| Marketing Authorisation Holder | Teva B.V., Swensweg 5, Haarlem, Nizozemska |
| Marketing Authorisation Date | 31.03.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/22-02/133 |
| Registration Number | 381-12-01/70-23-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | neponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | A04AD12 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
